On Feb. 13, the Food and Drug Administration (FDA) inspected KP Pharmaceutical Technology in Bloomington regarding drug quality assurance, according to data released on the FDA’s website.
The organization was not required to make any changes to its management practices following the final inspection report.
The FDA regularly reviews facilities throughout the United States to ensure workplaces and products meet FDA regulations that aim to protect public health. The results from these inspections are publicly posted.
The FDA’s website states that the agency oversees the safety and quality of human and animal drugs, biological products, medical devices, and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
